Explore All Access
Check if your research matches the topics covered in Expert Opinion on Orphan Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Expert Opinion on Orphan Drugs : Impact Factor & More
eISSN: 2167-8707pISSN: 2167-8707
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Expert Opinion on Orphan Drugs Key Metrics
CiteScore 
1.7
Impact Factor
< 5
SJR
Q3Health Policy
SNIP
0.3
Topics Covered on Expert Opinion on Orphan Drugs
Stargardt disease
Rare disease
Rituximab
Quality of life
Rare cancer
Immunotherapy
Hematopoietic stem cell transplantation
Treatment options
Orphan drug
Adrenal insufficiency
Cystic fibrosis
Symptom burden
Biliary cirrhosis
Chagas disease
Choroideremia
Eculizumab
Liver transplantation
Gene replacement
Antisense oligonucleotides
Expert Opinion on Orphan Drugs Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Expert Opinion on Orphan Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Orphan Drugs
Amyloidosis in Australia
- 4 Jan 2019
- Expert Opinion on Orphan Drugs
The opportunities and challenges of biosimilar orphans
- 7 Apr 2016
- Expert Opinion on Orphan Drugs
Review of Phase II and Phase III clinical trials for Duchenne muscular dystrophy
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Orphan drugs for the treatment of hairy cell leukemia
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Understanding molecular pathways and the identification of subgroups of patients with specific biomarker predictors of drug response related to orphan drugs
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Amyloidosis in Australia
- 4 Jan 2019
- Expert Opinion on Orphan Drugs
The opportunities and challenges of biosimilar orphans
- 7 Apr 2016
- Expert Opinion on Orphan Drugs
Review of Phase II and Phase III clinical trials for Duchenne muscular dystrophy
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Orphan drugs for the treatment of hairy cell leukemia
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Understanding molecular pathways and the identification of subgroups of patients with specific biomarker predictors of drug response related to orphan drugs
- 1 Jan 2013
- Expert Opinion on Orphan Drugs
Compare Similar Journals with Expert Opinion on Orphan Drugs
Select Journals to Compare with Expert Opinion on Orphan Drugs
Total journals - 9
You can select up to 3 Journals at a time
Molecular Genetics and Metabolism
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE
Orphanet Journal of Rare Diseases
Publisher: BMC
International Journal of Molecular Sciences
Publisher: MDPI
Blood
Publisher: AMER SOC HEMATOLOGY
Journal of Clinical Medicine
Publisher: MDPI
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Scientific Reports
Publisher: NATURE PORTFOLIO
0 Journals Selected to compare with
Expert Opinion on Orphan Drugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Expert Opinion on Orphan Drugs
How long has Expert Opinion on Orphan Drugs been actively publishing? 
Expert Opinion on Orphan Drugs has been in operation since 2013 till date.
What is the publishing frequency of Expert Opinion on Orphan Drugs?
Expert Opinion on Orphan Drugs published with a Monthly frequency.
How many articles did Expert Opinion on Orphan Drugs publish last year?
In 2023, Expert Opinion on Orphan Drugs publsihed undefined articles.
What is the eISSN & pISSN for Expert Opinion on Orphan Drugs?
For Expert Opinion on Orphan Drugs, eISSN is 2167-8707 and pISSN is 2167-8707.
What is Citescore for Expert Opinion on Orphan Drugs?
Citescore for Expert Opinion on Orphan Drugs is 1.7.
What is SNIP score for Expert Opinion on Orphan Drugs?
SNIP score for Expert Opinion on Orphan Drugs is 0.3.
What is the SJR for Expert Opinion on Orphan Drugs?
SJR for Expert Opinion on Orphan Drugs is Q3.
Who is the publisher of Expert Opinion on Orphan Drugs?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Orphan Drugs.
